Jun 2026 (Q2 FY26) — Aug 6, 2026
NN, Inc. Q2 FY26 — Strong Growth, Strategic Refinancing, and Expanding High-Value Markets
Read the full callNN (NNBR) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
NN earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 129 | +19.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 0.8 | +2.1 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -2.3 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$3.7 +8.50% · +$0.29
Performance +111.4% 1Y
1Y: $1.75 on 17 Oct 2025 → $3.7. High $4.51 (2 Oct 2026), low $1.14 (10 Dec 2025).
- Previous close
- $3.41
- 52-week range
- $1.14 – $4.51
- One year
- +98.92%
Overview
- Symbol
- NNBR
- Sector
- Industrials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
NN earnings calls (NNBR)
Financials
What the filings say
Net profit, year on year: +72% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 114 | 107 | 106 | 108 | 104 | 105 | 118 | 129 |
| Operating profit | -4 | -17 | -5 | -1 | -2 | -10 | -2 | 1 |
| Operating margin | −3.3% | −15.8% | −4.5% | −1.4% | −2.2% | −9.9% | −1.7% | 0.8% |
| Interest | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 |
| Profit before tax | -4 | -23 | -8 | -10 | -8 | -15 | -8 | -4 |
| Tax rate | −23.5% | −5.3% | −16.8% | −8.1% | −10.4% | −1.8% | −8.6% | −4.2% |
| Net profit | -3 | -21 | -7 | -8 | -7 | -13 | -7 | -2 |
| EPS ($ per share) | -0.13 | — | -0.23 | -0.26 | -0.23 | — | -0.25 | -0.13 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| Reserves | -58 | -105 | -206 | -219 | -245 | -295 | -334 | -368 |
| Total liabilities | 1,082 | 1,096 | 266 | 301 | 295 | 308 | 289 | 294 |
| Fixed assets | 361 | 256 | 224 | 209 | 198 | 186 | 162 | 159 |
| Total assets | 1,501 | 1,542 | 625 | 579 | 546 | 511 | 457 | 441 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 41 | 49 | 16 | 16 | 8 | 29 | 11 | 6 |
| Cash from investing | -461 | -39 | 719 | -36 | -17 | -18 | -1 | -11 |
| Cash from financing | 215 | 5 | -715 | 3 | -5 | -3 | -13 | -2 |
| Net cash flow | -206 | 14 | 16 | -19 | -16 | 9 | -4 | -7 |
| Capital expenditure | -64 | -54 | -24 | -18 | -18 | -20 | -18 | -13 |
| Free cash flow | -23 | -5 | -8 | -3 | -10 | 9 | -7 | -7 |
Insider filings
46 filings between Mar 18, 2026 and Jul 8, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$7.91M
28 sales by 3 insiders
Compensation
not trading decisions- 10
- Award — granted as compensation
- 1
- Option exercise — converted options into shares
- 7
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Corre Partners Management, LLC | — | $3.93M | Apr 27, 2026 |
| Barrett John Frederick | — | $3.93M | Apr 27, 2026 |
| White Raymond T. | — | $45.3K | May 12, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 8, 2026 | STATHAM JAMI SVP, General Counsel | Tax withheld | 1,514 | $5.3K |
| Jun 25, 2026 | Bohnert Christopher H SVP, Chief Financial Officer | Tax withheld | 9,205 | $24.7K |
| Jun 8, 2026 | Esch Robert James Pres. & CTO, Machined Products | Award | 6,600 | $0 |
| May 22, 2026 | Bevis Harold C President and CEO | Tax withheld | 130,312 | $319.3K |
| May 12, 2026 | White Raymond T. Director | Sale | 18,782 | $45.3K |
| Apr 27, 2026 | Barrett John Frederick 10% owner | Sale | 136,165 | $358.0K |
| Apr 27, 2026 | Corre Partners Management, LLC 10% owner | Sale | 99,745 | $262.3K |
| Apr 27, 2026 | Corre Partners Management, LLC 10% owner | Sale | 36,420 | $95.8K |
| Apr 24, 2026 | Barrett John Frederick 10% owner | Sale | 12,199 | $30.7K |
| Apr 24, 2026 | Corre Partners Management, LLC 10% owner | Sale | 8,936 | $22.5K |
| Apr 24, 2026 | Corre Partners Management, LLC 10% owner | Sale | 3,263 | $8.2K |
| Apr 23, 2026 | Barrett John Frederick 10% owner | Sale | 555,305 | $1.49M |
| Apr 23, 2026 | Corre Partners Management, LLC 10% owner | Sale | 406,779 | $1.09M |
| Apr 23, 2026 | Corre Partners Management, LLC 10% owner | Sale | 148,526 | $399.6K |
| Apr 22, 2026 | Barrett John Frederick 10% owner | Sale | 94,380 | $216.9K |
| Apr 22, 2026 | Corre Partners Management, LLC 10% owner | Sale | 69,136 | $158.9K |
| Apr 22, 2026 | Corre Partners Management, LLC 10% owner | Sale | 25,244 | $58.0K |
| Apr 21, 2026 | Barrett John Frederick 10% owner | Sale | 55,483 | $122.6K |
| Apr 21, 2026 | Corre Partners Management, LLC 10% owner | Sale | 14,840 | $32.8K |
| Apr 21, 2026 | Corre Partners Management, LLC 10% owner | Sale | 40,643 | $89.8K |
| Apr 20, 2026 | Barrett John Frederick 10% owner | Sale | 79,757 | $178.8K |
| Apr 20, 2026 | Corre Partners Management, LLC 10% owner | Sale | 58,425 | $131.0K |
| Apr 20, 2026 | Corre Partners Management, LLC 10% owner | Sale | 21,332 | $47.8K |
| Apr 17, 2026 | Barrett John Frederick 10% owner | Sale | 348,161 | $798.6K |
| Apr 17, 2026 | Corre Partners Management, LLC 10% owner | Sale | 93,122 | $213.6K |
| Apr 17, 2026 | Corre Partners Management, LLC 10% owner | Sale | 255,039 | $585.0K |
| Apr 16, 2026 | Barrett John Frederick 10% owner | Sale | 40,030 | $81.7K |
| Apr 16, 2026 | Corre Partners Management, LLC 10% owner | Sale | 10,707 | $21.9K |
| Apr 16, 2026 | Corre Partners Management, LLC 10% owner | Sale | 29,323 | $59.9K |
| Apr 15, 2026 | Barrett John Frederick 10% owner | Sale | 315,436 | $648.6K |
| Apr 15, 2026 | Corre Partners Management, LLC 10% owner | Sale | 84,369 | $173.5K |
| Apr 15, 2026 | Corre Partners Management, LLC 10% owner | Sale | 231,067 | $475.1K |
| Apr 1, 2026 | NIXON D. GAIL Senior VP, Human Resources | Tax withheld | 5,855 | $8.5K |
| Mar 19, 2026 | NIXON D. GAIL Senior VP, Human Resources | Tax withheld | 1,249 | $1.8K |
| Mar 18, 2026 | BENVENUTI RAYNARD D. Director | Award | 51,774 | $0 |
| Mar 18, 2026 | STATHAM JAMI SVP, General Counsel | Award | 80,623 | $0 |
| Mar 18, 2026 | STATHAM JAMI SVP, General Counsel | Tax withheld | 4,395 | $5.4K |
| Mar 18, 2026 | White Raymond T. Director | Award | 49,079 | $0 |
| Mar 18, 2026 | HARMAN JERI J Director | Award | 51,774 | $0 |
| Mar 18, 2026 | Wilson Thomas Hampton Jr. Director | Award | 51,774 | $0 |
| Mar 18, 2026 | Gautam Rajeev Director | Award | 51,774 | $0 |
| Mar 18, 2026 | Faria Joao V Director | Award | 51,774 | $0 |
| Mar 18, 2026 | NIXON D. GAIL Senior VP, Human Resources | Award | 53,726 | $0 |
| Mar 18, 2026 | NIXON D. GAIL Senior VP, Human Resources | Option exercise | 123,520 | — |
| Mar 18, 2026 | NIXON D. GAIL Senior VP, Human Resources | Tax withheld | 42,427 | $52.2K |
| Mar 18, 2026 | Carroll Christina Director | Award | 51,774 | $0 |
| Jul 8, 2025 | STATHAM JAMI SVP, General Counsel | Tax withheld | 1,515 | $3.3K |
| Jun 25, 2025 | Bohnert Christopher H SVP, Chief Financial Officer | Tax withheld | 10,981 | $21.4K |
| May 22, 2025 | Bevis Harold C President and CEO | Tax withheld | 131,100 | $249.1K |
| May 14, 2025 | Bevis Harold C President and CEO | Purchase | 45,316 | $99.6K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for NN INC
Free account. Everything above stays public.
Write why you follow NN INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading